|Articles|September 1, 2003
- Pharmaceutical Executive-09-01-2003
Table of Contents
Table of Contents
Advertisement
Articles in this issue
almost 23 years ago
The Outsideralmost 23 years ago
PE's annual Media Spend Trendsalmost 23 years ago
A New Deal with Managed Carealmost 23 years ago
Matters of (Re)Importalmost 23 years ago
Show Us the ValueAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The New Healthy Aging Imperative and What It Means for Pharma
2
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
3
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
4
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
5